AI Summary & Key Takeaways
AI InsightWe think the present study's findings are important for healthcare providers and will contribute significantly to the understanding of the relationship between CTS and pregnancy by shedding light on the relationship between relevant variables and the prevalence of CTS.
📌 3 Key Takeaways
Abstract
Aim: The purpose of our study was to highlight CTS, which is generally overlooked by physicians in pregnant, resulting in inadequate diagnosis and treatment, and to investigate the related risk factors in pregnant who are diagnosed with CTS. Materials and Methods: In our study, the demographic, clinical, and laboratory data of 82 pregnant, who were diagnosed with CTS, who were in the 3rd trimester, and whose pregnancy follow-ups were performed by us between March 2018-2023, and 82 pregnant in the control group were assessed retrospectively. Results: BMI values were observed to be significantly greater in the group with CTS compared to the group without CTS(p:0.036). The HbA1c level was 5.4±0.2 in the group with CTS, and 5.1±0.3 in the group without CTS, and it was significantly higher in the group with CTS(p:0.038).The TSH level was 2.9±0.6(mIU/L) in the group with CTS, and 2.4±0.5(mIU/L) in the group without CTS, and it was significantly greater in the group with CTS(p:0.042). A positive, statistically significant, and moderate correlation was detected between the CTS-6 value and BMI score (p:0.006, r=0.438). Another statistically significant, positive, and weak correlation was detected between the CTS-6 score and HbA1c level(p:0.028, r=0.234). Conclusion: It is especially important to pay attention to many risk factors because subclinical CTS during pregnancy can lead to permanent complications. We think the present study's findings are important for healthcare providers and will contribute significantly to the understanding of the relationship between CTS and pregnancy by shedding light on the relationship between relevant variables and the prevalence of CTS.
Özet
Amaç: Bu çalışmanın amacı gebelerde genellikle hekimler tarafından gözden kaçırılan, tanı ve tedavide yetersizliğe neden olan Karpal tunel sendromunu (KTS) vurgulamak ve KTS tanısı alan gebelerde ilişkili risk faktörlerini araştırmaktır. Gereç ve yöntemler: Bu çalışmada Mart 2018 - Mart 2023 tarihleri arasında hastanemizde gebelik takipleri yapılan, 3. trimesterde KTS tanısı alan 82 gebe ile kontrol grubundaki 82 gebenin demografik, klinik ve laboratuvar verileri retrospektif olarak değerlendirildi. Bulgular: KTS saptanan grupta beden kitle indeksi (BMI) düzeyi saptanmayan gruba göre anlamlı derecede yüksek saptandı (p:0.036). HbA1c düzeyi KTS saptanan grupta 5.4±0.2, saptanmayan grupta ise 5.1±0.3 olup KTS grubunda anlamlı olarak yüksek saptandı (p:0.038). TSH düzeyi KTS saptanan grupta 2.9±0.6 (mIU/L), saptanmayan grupta ise 2.4±0.5 (mIU/L) olup, KTS grubunda anlamlı olarak yüksek saptandı (p:0.042). KTS-6 değeri ile BMI skoru arasında pozitif, istatistiksel olarak anlamlı ve orta düzeyde bir korelasyon tespit edildi (p:0.006, r=0.438). KTS-6 skoru ile HbA1c düzeyi arasında istatistiksel olarak anlamlı, pozitif ve zayıf bir korelasyon daha tespit edildi (p:0.028, r=0.234). Sonuç: Gebelikte subklinik KTS kalıcı komplikasyonlara neden olabileceğinden birçok risk faktörüne dikkat etmek özellikle önemlidir. Bu çalışmanın bulgularının sağlık çalışanları açısından önemli olduğunu ve ilgili değişkenler ile KTS prevalansı arasındaki ilişkiye ışık tutarak KTS ile gebelik arasındaki ilişkinin anlaşılmasına önemli katkı sağlayacağını düşünüyoruz.